These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 17222343

  • 1. Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines.
    Koshimune R, Aoe M, Toyooka S, Hara F, Ouchida M, Tokumo M, Sano Y, Date H, Shimizu N.
    BMC Cancer; 2007 Jan 12; 7():8. PubMed ID: 17222343
    [Abstract] [Full Text] [Related]

  • 2. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY, Chang JW, Chou WC, Liaw CC, Wang HM, Huang JS, Wang CH, Yeh KY.
    Lung Cancer; 2008 Feb 12; 59(2):180-91. PubMed ID: 17900752
    [Abstract] [Full Text] [Related]

  • 3. Zoledronic acid, a third-generation bisphosphonate, inhibits cellular growth and induces apoptosis in oral carcinoma cell lines.
    Tamura T, Shomori K, Nakabayashi M, Fujii N, Ryoke K, Ito H.
    Oncol Rep; 2011 Apr 12; 25(4):1139-43. PubMed ID: 21249320
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Darbufelone, a novel anti-inflammatory drug, induces growth inhibition of lung cancer cells both in vitro and in vivo.
    Ye X, Zhou W, Li Y, Sun Y, Zhang Y, Ji H, Lai Y.
    Cancer Chemother Pharmacol; 2010 Jul 12; 66(2):277-85. PubMed ID: 20352217
    [Abstract] [Full Text] [Related]

  • 6. Molecular targets of the chemopreventive agent 1,4-phenylenebis (methylene)-selenocyanate in human non-small cell lung cancer.
    El-Bayoumy K, Das A, Narayanan B, Narayanan N, Fiala ES, Desai D, Rao CV, Amin S, Sinha R.
    Carcinogenesis; 2006 Jul 12; 27(7):1369-76. PubMed ID: 16399772
    [Abstract] [Full Text] [Related]

  • 7. The synergistic effect of dimethylamino benzoylphenylurea (NSC #639829) and X-irradiation on human lung carcinoma cell lines.
    Balcer-Kubiczek EK, Attarpour M, Edelman MJ.
    Cancer Chemother Pharmacol; 2007 May 12; 59(6):781-7. PubMed ID: 16957930
    [Abstract] [Full Text] [Related]

  • 8. A synthetic naringenin derivative, 5-hydroxy-7,4'-diacetyloxyflavanone-N-phenyl hydrazone (N101-43), induces apoptosis through up-regulation of Fas/FasL expression and inhibition of PI3K/Akt signaling pathways in non-small-cell lung cancer cells.
    Bak Y, Kim H, Kang JW, Lee DH, Kim MS, Park YS, Kim JH, Jung KY, Lim Y, Hong J, Yoon DY.
    J Agric Food Chem; 2011 Sep 28; 59(18):10286-97. PubMed ID: 21877710
    [Abstract] [Full Text] [Related]

  • 9. Induction of mitochondria-dependent apoptosis through the inhibition of mevalonate pathway in human breast cancer cells by YM529, a new third generation bisphosphonate.
    Nakajima H, Magae J, Tsuruga M, Sakaguchi K, Fujiwara I, Mizuta M, Sawai K, Yamagishi H, Mizuta N.
    Cancer Lett; 2007 Aug 08; 253(1):89-96. PubMed ID: 17316980
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
    Chattopadhyay S, Machado-Pinilla R, Manguan-García C, Belda-Iniesta C, Moratilla C, Cejas P, Fresno-Vara JA, de Castro-Carpeño J, Casado E, Nistal M, Gonzalez-Barón M, Perona R.
    Oncogene; 2006 Jun 01; 25(23):3335-45. PubMed ID: 16462770
    [Abstract] [Full Text] [Related]

  • 13. Epidermal growth factor receptor monoclonal antibodies inhibit the growth of lung cancer cell lines.
    Lee M, Draoui M, Zia F, Gazdar A, Oie H, Bepler G, Bellot F, Tarr C, Kris R, Moody TW.
    J Natl Cancer Inst Monogr; 1992 Jun 01; (13):117-23. PubMed ID: 1327029
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The third-generation bisphosphonates inhibit proliferation of murine osteosarcoma cells with induction of apoptosis.
    Horie N, Murata H, Nishigaki Y, Matsui T, Segawa H, Nogawa M, Yuasa T, Kimura S, Maekawa T, Fushiki S, Kubo T.
    Cancer Lett; 2006 Jul 08; 238(1):111-8. PubMed ID: 16112430
    [Abstract] [Full Text] [Related]

  • 18. Strong anti-tumor effect of NVP-AUY922, a novel Hsp90 inhibitor, on non-small cell lung cancer.
    Ueno T, Tsukuda K, Toyooka S, Ando M, Takaoka M, Soh J, Asano H, Maki Y, Muraoka T, Tanaka N, Shien K, Furukawa M, Yamatsuji T, Kiura K, Naomoto Y, Miyoshi S.
    Lung Cancer; 2012 Apr 08; 76(1):26-31. PubMed ID: 21996088
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines.
    Murayama T, Kawasoe Y, Yamashita Y, Ueno Y, Minami S, Yokouchi M, Komiya S.
    Anticancer Res; 2008 Apr 08; 28(4B):2147-54. PubMed ID: 18751388
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.